Proventis Med

🗓 Founded 2025👥 4 employees💰 Last funded Feb 2026
Public Health
LinkedIn
Proventis is pioneering the future of male contraception with a reliable, long-term, reversible implant designed to empower men with proactive family planning. With unintended pregnancies constituting 40% of annual pregnancies worldwide, there is a growing need for male contraception methods, other than condoms and vasectomy. Our innovative set-and-forget implant will provide men with a reliable contraceptive protection without the need for daily attention or interruption. It is designed to conveniently be placed by a physician in a quick, minimally invasive, in-office procedure, and similarly deactivated upon request, to regain fertility. At Proventis, we are dedicated to advancing reproductive health through scientific excellence and strategic collaborations. We invite leading urologists, key opinion leaders, and forward-thinking investors to join us on our mission to redefine the landscape of male contraceptives. 
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Proventis Med?
Proventis Med has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Proventis Med last raise funding?
The most recent investment in Proventis Med recorded on gritt.io was in February 2026.
When was Proventis Med founded?
Proventis Med was founded in 2025.
What industry is Proventis Med in?
Proventis Med operates in Public Health. Find similar Public Health investors on gritt.io.